AJULYF
Live / Registered — Registered (as of 30 Apr 2024)
What this means for you
Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97884490
- Registration number
- 7373541
- Mark type
- Stylized text
- Filed
- 12 Apr 2023
- Published for opposition
- 13 Feb 2024
- Registered
- 30 Apr 2024
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Feb 2024 — PUBLISHED FOR OPPOSITION
- 24 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jan 2024 — ASSIGNED TO EXAMINER
- 27 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Apr 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Apr 2023 — NEW APPLICATION ENTERED